Literature DB >> 26426167

The Protective Effect of Epigallocatechin-3-gallate on Paraquat-induced Haemolysis.

K Moses1, D Pepple1, P Singh2.   

Abstract

Epigallocatechin-3-gallate (EGCG) is a major ingredient present in green tea, which has a high antioxidant activity. In this study, the effect of EGCG was investigated on paraquat-induced haemolysis of erythrocyte membrane. Erythrocytes were incubated in 0.03, 0.3, 3.0 and 30 mg/mL EGCG, respectively and exposed to 30 mg/mL of paraquat for 10 minutes. The effect of paraquat was determined by an analysis of the osmotic fragility of the erythrocytes. The results showed that EGCG (30 mg/mL) significantly (p < 0.05) reduced the haemolysis of erythrocytes exposed to paraquat (5.0 mg/mL). This suggests that EGCG may have a protective effect on paraquat-induced erythrocyte membrane haemolysis and that consumption of green tea, with high EGCG concentration, could ameliorate the deleterious effect of paraquat toxicity on the haemolysis of erythrocyte membrane.

Entities:  

Year:  2015        PMID: 26426167      PMCID: PMC4763888          DOI: 10.7727/wimj.2014.067

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  12 in total

Review 1.  Manifestations and management of paraquat poisoning.

Authors:  S M Pond
Journal:  Med J Aust       Date:  1990-03-05       Impact factor: 7.738

2.  Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype.

Authors:  Lucio Luzzatto
Journal:  Haematologica       Date:  2006-10       Impact factor: 9.941

3.  Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity.

Authors:  J S Bus; S D Aust; J E Gibson
Journal:  Biochem Biophys Res Commun       Date:  1974-06-04       Impact factor: 3.575

Review 4.  Acute pesticide poisoning in the Caribbean.

Authors:  P D Singh; M E West
Journal:  West Indian Med J       Date:  1985-06       Impact factor: 0.171

5.  Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes.

Authors:  Syed Ibrahim Rizvi; Mohd Abu Zaid; Rafat Anis; Neetu Mishra
Journal:  Clin Exp Pharmacol Physiol       Date:  2005 Jan-Feb       Impact factor: 2.557

6.  Improving effects of epigallocatechin-3-gallate on hemorheological abnormalities of aging Guinea pigs.

Authors:  Huey-Chuan Cheng; Chi-Ming Chan; Hsin-Sheng Tsay; Hong-Jen Liang; Yu-Chih Liang; Der-Zen Liu
Journal:  Circ J       Date:  2007-04       Impact factor: 2.993

7.  Effect of zinc deficiency and food restriction in rats on erythrocyte membrane zinc, phospholipid and protein content.

Authors:  G L Johanning; B L O'Dell
Journal:  J Nutr       Date:  1989-11       Impact factor: 4.798

8.  Mechanism of free radical-induced hemolysis of human erythrocytes: hemolysis by water-soluble radical initiator.

Authors:  Y Sato; S Kamo; T Takahashi; Y Suzuki
Journal:  Biochemistry       Date:  1995-07-18       Impact factor: 3.162

Review 9.  Role of antioxidants in paraquat toxicity.

Authors:  Zacharias E Suntres
Journal:  Toxicology       Date:  2002-10-30       Impact factor: 4.221

10.  Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation--a mechanism of protective effects of EGCg against paraquat toxicity.

Authors:  Akihiro Higuchi; Kosei Yonemitsu; Ako Koreeda; Shigeyuki Tsunenari
Journal:  Toxicology       Date:  2003-02-01       Impact factor: 4.221

View more
  2 in total

1.  Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study.

Authors:  Jose Enrique de la Rubia Ortí; Jose Luis Platero; María Benlloch; Lorena Franco-Martinez; Asta Tvarijonaviciute; Jesús Escribá-Alepuz; Sandra Sancho-Castillo
Journal:  Biomolecules       Date:  2021-04-21

2.  Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study.

Authors:  Gamal Shiha; Reham Soliman; Mohamed Elbasiony; Noureldien H E Darwish; Shaker A Mousa
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.